Guizhou Xinbang Pharmaceutical Co., Ltd. announced that at its Extraordinary General Meeting of 2024 held on 20 February 2024, elected An Ji, Kong Lingzhong, Ding Yi, Ma Qianxian, Lv Xiangqian as non-independent director. Qiu Gang, Liu Jie, Liu Yifeng as independent director and Huang Yongjia, shareholder supervisor.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.02 CNY | -0.74% | +1.52% | -9.46% |
09/05 | Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Cash Dividend for 2023 | CI |
28/04 | Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.46% | 106.08Cr | |
+40.09% | 615.77Cr | |
-16.34% | 446.26Cr | |
-7.11% | 326.89Cr | |
+5.14% | 319.78Cr | |
-0.18% | 259.92Cr | |
+47.93% | 197.54Cr | |
-7.15% | 169.77Cr | |
+0.67% | 166.12Cr | |
-8.73% | 160.9Cr |
- Stock Market
- Equities
- 002390 Stock
- News Guizhou Xinbang Pharmaceutical Co., Ltd.
- Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Board Appointments